
Tandem Mobi
Prescription subcutaneous insulin delivery; regional Control-IQ+ eligibility applies.
Tubeless insulin pod automates delivery from compatible CGM readings through an app or controller.
Manufacturer product imagery; shown for product identification.
No verified price in this audit.
Omnipod 5 is a prescribed controller/pod supply configuration with pharmacy coverage. Current maker amounts are insurance/copay or trial assistance; Australian prosthesis-list reimbursement rates are not a verified cash retail purchase quote.
Prescription/benefits check and compatible CGM required; pharmacy access varies by coverage.
Prices are snapshots, not a live stock feed. Taxes, shipping, prescription lenses and accessories can change the total.

Prescription subcutaneous insulin delivery; regional Control-IQ+ eligibility applies.

Prescription subcutaneous insulin delivery; regional Control-IQ+ eligibility applies.

Prescription insulin delivery for type 1 age 7+ and type 2 adults 18+ per current US labelling.
Own it, tried it, or still deciding? Share what matters to you.
Start the conversation.
No comments yet. Your experience could help the next person choose.